Výsledky vyhledávání - "R. M. Ismakov"

An observational multicenter study to evaluate the efficacy and safety of degarelix® for prostate cancer in routine clinical practice

Autor: K. M. Nyushko, B. Ya. Alekseev, V. M. Perepukhov, I. M. Shevchuk, V. A. Atduev, А. B. Zdobnikov, V. B. Venskel, Е. V. Gurin, A. V. Eremenko, I. V. Belov, V. D. Gavrilova, R. M. Ismakov, D. G. Prokhorov, R. V. Nikitin, E. A. Usinin, E. I. Kopyltsov, O. V. Leonov, А. O. Leonov

Publikováno v: Cancer Urology. 18:102-110

Background. Prostate cancer (PCa) is an actual disease and a frequent oncological pathology in men. The main methods of radical treatment of patients with PCa are radical prostatectomy and radiation therapy. Radical prostatectomy s the most commonly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::273f5fc20476a0b2caa7a171afd9a2bf
https://doi.org/10.17650/1726-9776-2022-18-2-102-110

Zobrazit plný text záznamu

Radionuclide therapy with radium-223 chloride. A few strokes to the patient’s portrait

Autor: V. N. Oschepkov, P. B. Zotov, R. M. Ismakov, A. M. Khazimov, I. D. Tukmanbetov

Publikováno v: Onkourologiâ, Vol 14, Iss 4, Pp 87-94 (2019)

Radium-223 is the 1 st nuclide medicine from the group of alpha emitters, its use is associated with an increase in overall survival, a delay to bone complications and a significant improvement the quality of life, proven placebo-controlled randomize

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31bf082047cfea91cd5c8b9e6465560d
https://doi.org/10.17650/1726-9776-2018-14-4-87-94

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání